Representative Maurice Hinchey (D-NY) complimented the Union of Concerned Scientists for conducting the study and shedding light on the “serious and widespread problems at FDA.”
He described what he said he thinks is at the heart of many of FDA's problems: “close alignment with and financial ties to the pharmaceutical and device industries it is supposed to regulate.”
“The cozy relationship between FDA and industry has resulted in the agency being dependent on industry funds for its budget, which has in turn made FDA beholden to drug company interests,” Rep. Hinchey said.
“Right now, FDA has to negotiate with companies about how it will use those funds, and the agency is powerless to demand label changes. We need to separate the financial link between the two entities. And we must return FDA to a time when science was the only consideration for approving a drug—not politics.”